Lung Small Cell Carcinoma
Oncology
6 drugs in development·3 companies·1 clinical trial
Drug Pipeline by Phase
Phase 2(4)
Phase 1(1)
| Drug | Company |
|---|---|
| Iadademstat | ENANTA PHARMACEUTICALS INC (ENTA) |
Phase 4(1)
| Drug | Company |
|---|---|
| monalizumab | GH Research PLC (GHRS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Lung Small Cell Carcinoma?
BioSniper tracks 6 drugs in development for Lung Small Cell Carcinoma across 3 companies.
How many clinical trials target Lung Small Cell Carcinoma?
There are 1 clinical trial targeting Lung Small Cell Carcinoma tracked by BioSniper.
Deep-dive into Lung Small Cell Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis